Total Pharmaceuticals industry deals worth $5.7bn were announced globally for August 2022, with Bain Capital's $3.12bn private equity deal with Evident being the sector's biggest investment, according to GlobalData's deals database.

The value marked a decrease of 39.5% over the earlier month of $9.36bn and a drop of 54.7% when compared with the last 12-month average of $12.48bn.

In terms of number of deals, the sector saw a drop of 21.89% with 157 deals in August 2022 when compared to the last 12-month average of 201 deals.

For more Pharma M&A Deals therapy area insights, download a free sample

In value terms, Asia-Pacific drove the activity with deals worth $3.35bn in August 2022.

Medical Devices industry deals in August 2022: Top deals

The top five deals accounted for 76.2% of the overall value during August 2022.

The combined value of the top five deals stood at $4.31bn, against the overall value of $5.7bn recorded for the month.

The top five medical devices industry deals of August 2022 tracked by GlobalData were:

1) Bain Capital's $3.12bn private equity deal with Evident

2) The $468.22m acquisition of B Medical Systems by Azenta

3) Teleflex's $300m acquisition deal with Standard Bariatrics

4) The $250m acquisition of Biorez by ConMed

5) Bio-Rad Laboratories' $170m acquisition deal with Curiosity Diagnostics

Comments

Post a Comment

Popular posts from this blog

ETView wins Chinese approval for VivaSight-SL airway management device

The Chinese State Food and Drug Organization (SFDA) ihas cleared the pre-marketing warning application for ETView Clinical's VivaSight-SL airway management devices market . The gadget, which is remembered for the organization's protected VivaSight airway management portfolio, is a solitary utilize expendable single lumen ventilation tube with a coordinated constant high goal video imaging framework, for use in lung separation systems like thoracic, cardiovascular, vascular or esophageal medical procedures. The organization, which expects extra pre-market administrative clearances during 2013, said the gadget will be dispersed all through China by Sinopharm. ETView President Bill Edelman said the organization expects huge clinical interest where the item is cleared for business circulation. "With our line of VivaSight items accessible in the US, South America, Europe and presently China, ETView offers a total airway management answer for 100 percent of lung-confinement medi...
Read more

US has lowest diagnosis rate for rheumatoid arthritis compared with other major markets

 Despite the fact that it can happen at whatever stage in life, the illness might begin affecting individuals between the ages of 30 to 60 years. Rheumatoid arthritis (RA) is an ongoing condition that is a consequence of an immune system problem. In spite of the fact that it can happen at whatever stage in life, the illness might begin affecting individuals between the ages of 30 to 60 years. Ladies are likewise bound to foster the condition, contrasted with men. Rheumatoid arthritis pervasiveness GlobalData disease transmission specialists assessed that in 2018, the US had the least finding pace of common cases of RA, at 67%, contrasted with different nations in the eight significant markets (8MM: the US, France, Germany, Italy, Spain, the UK, Japan and Australia). Generally, the 8MM had a finding pace of roughly 73%. The UK had the most noteworthy analysis rate, 84%, contrasted with different nations in the 8MM. Notwithstanding, despite the fact that the US has most minimal conc...
Read more

MRI-based imaging technology avoids contrast agents

A research group at Purdue College in the US has fostered another scientific imaging innovation that eliminates the requirement for contrast agents to recognize and screen cerebral vascular issues and injuries in the brain. The new methodology depends on practical X-ray and searches for an intrinsic blood-related X-ray signal, which is utilized as a characteristic biomarker to follow blood stream in a patient. Cerebral course time is the defer that happens during the movement of intrinsic signs from the internal carotid supply route to the internal jugular vein. A drawn out time delay is seen as blood stream unsettling influence in the brain, possibly because of a cancer, horrendous brain injury or other brain illnesses. Purdue College Weldon School of Biomedical Engineering colleague teacher Yunjie Tong said: "We can think about the sign from symmetric supply routes and veins in the two halves of the globe or neck to survey the cerebrovascular integrity or the equilibrium of bloo...
Read more